
An experimental vaccine has shown promise in treating patients with advanced solid cancers, a study has found.
The mRNA cancer immunotherapy treatment developed by Moderna is targeted for patients with lung cancer, melanoma and other tumours.

An experimental vaccine has shown promise in treating patients with advanced solid cancers, a study has found.
The mRNA cancer immunotherapy treatment developed by Moderna is targeted for patients with lung cancer, melanoma and other tumours.